Calvert Research and Auburn University Announce Joint Venture | CALVERT Research

Calvert Research and Auburn University Announce Joint Venture

by Jeff Tippett on October 3, 2008

Strategic Partnership Focuses on Target Drug Delivery

Calvert Research and Auburn University announced a joint research project entitled Targeted Drug Delivery.  Undertaken through the Auburn University Department of Pathobiology, the six-month study is under the direction of Dr. Valery Petrenko. Dr. Lonnie Bookbinder, West Coast Regional Director, is coordinating the research on behalf of Calvert Research.

The study will center on the hypothesis that targeting siRNA-containing pharmaceutical nanocarriers, such as liposomes, with breast tumor-specific phage proteins may significantly enhance their anti-cancer activity. “This particular study was selected after an extensive nationwide effort to research numerous potential delivery technologies,” stated Dr. Booklbinder.  He continued by adding: “Calvert Research looks forward to advancing science through this partnership with Auburn University and Dr. Petrenko.”

“The Auburn project fits our plans to invest in novel  therapeutic approaches that will advance clinical development of new  drug compounds. We share the belief that future pharmaceuticals and biologicals will have targeted delivery,” explained Russ McLauchlan, CEO of Calvert Holdings, Inc.  “Our alliance with Auburn University gives us a position in this growing field.”

Scheduled to conclude in April 2009, the study’s results will be published by Auburn University.